Physician

Charles B Dabbs, M.D.

According to 2025 Medicare claims, Charles Dabbs, M.D. (NPI: 1427083732) practices ophthalmology in the Gadsden, AL market, with the plurality of this provider's patient population coming from Etowah, AL. This provider's primary affiliated billing organization is GADSDEN EYE ASSOCIATES P C (NPI: 1730281882; TIN: 63-0858777) and primary practice location at 35901-4224.

Dabbs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,193 traditional Medicare patients, billed 6,650 HCPCS/CPT codes, and received $621,593 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 3,945 prescription claims across 935 beneficiaries totaling $348,335 in drug costs, led by Restasis (Cyclosporine). 2021 DME data shows 12 claims. Open Payments data shows 49 records totaling $951. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,510	9,275	$834,709
2016	2,340	9,571	$798,770
2017	1,930	8,887	$691,092
2018	1,928	8,808	$722,184
2019	1,849	7,326	$719,331
2020	1,629	7,011	$650,926
2021	1,577	7,261	$700,825
2022	1,502	7,050	$684,461
2023	1,304	6,770	$608,961
2024	1,193	6,650	$621,593

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,082	4,450	$247,086
2016	749	3,075	$228,154
2017	786	3,325	$215,928
2018	768	3,310	$244,403
2019	796	3,346	$300,107
2020	771	3,136	$572,095
2021	891	3,560	$370,529
2022	837	3,462	$393,374
2023	818	3,459	$379,436
2024	935	3,945	$348,335

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	48	48	$2,650
2016	63	65	$3,640
2017	77	77	$5,417
2018	92	92	$5,738
2019	40	40	$2,447
2020	14	14	$824
2021	12	12	$728
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	937	1,437	$74
92012	Established patient problem focused exam of visual system	183	258	$53
92134	Imaging of retina	265	640	$27
92136	Measurement of corneal curvature and depth of eye	224	233	$26
92133	Imaging of optic nerve	167	208	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	48	2,760	$57,103
Lumigan	Bimatoprost	58	3,745	$34,477
Xiidra	Lifitegrast	24	1,200	$27,012
Cyclosporine	Cyclosporine	35	2,070	$25,621
Prednisolone Acetate	Prednisolone Acetate	467	14,918	$23,997

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$951	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles B. Dabbs, M.D.?

Tedicare shows public-source Medicare data for Charles B. Dabbs, M.D. (NPI 1427083732), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles B. Dabbs, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles B. Dabbs, M.D.?

Charles B. Dabbs, M.D. is linked to GADSDEN EYE ASSOCIATES P C (billing NPI 1730281882) in the available physician profile data.

Does Charles B. Dabbs, M.D. have Open Payments data?

Charles B. Dabbs, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.